Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

500 mg (14 tablets) US$236.60 † Moxifloxacin 400 mg p.o. or iv. q.d. Tablets: 400 mg (14 tablets) US$225.60 † † Approximate retail price from [101]. ‡ Average wholesale price from [102].

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge. Explore Teva Pharmaceutical Indus stock price, quotes, charts and forecasts with Benzinga. Stay updated on ...

Carpenter Technology Corp. $195.23 11.42 6.21% ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...

Pre-Market: 8:19:52 a.m. EDT Loading Chart for TEVA ...